Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atavistik Bio, Inc
Hoffmann-La Roche
Arcus Biosciences, Inc.
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
OHSU Knight Cancer Institute
Novartis
City of Hope Medical Center
EMD Serono
University Health Network, Toronto
NeoTX Therapeutics Ltd.
BicycleTx Limited
BicycleTx Limited
Memorial Sloan Kettering Cancer Center
Exelixis
Jonsson Comprehensive Cancer Center
Cancer Research UK
Toray Industries, Inc
Daiichi Sankyo
University of Alabama at Birmingham
Tempus AI
Memorial Sloan Kettering Cancer Center
Xencor, Inc.
Agenus Inc.
Carisma Therapeutics Inc
University of Toronto
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Adaptimmune
ImmunoVaccine Technologies, Inc. (IMV Inc.)